US FDA Approves Labcorp’s Companion Diagnostic Test for Advanced Melanoma: Here’s What To Know

The FDA has approved Labcorp’s PGDx elio tissue complete CDx to identify patients with melanoma with certain BRAF variants.

The FDA has approved Labcorp’s PGDx elio tissue complete CDx to identify patients with melanoma with certain BRAF variants.